Author

S. Buta

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

D. Bogunovic· 4 shared J. Taft· 4 shared M. Martin-Fernandez· 4 shared A. Shin· 3 shared K. Niazi· 3 shared P. Soon-Shiong· 3 shared R. S. Patel· 3 shared S. Rabizadeh· 3 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

D. Bogunovic

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

The Dual-Antigen Ad5 COVID-19 Vaccine Delivered as an Intranasal Plus Subcutaneous Prime Elicits Th1 Dominant T-Cell and Humoral Responses in CD-1 Mice

A. Rice, M. Verma, A. Shin, L. Zakin, P. Sieling, S. Tanaka, J. Balint, K. Dinkins, H. Adisetiyo, B. Morimoto, W. Higashide, J. Taft, R. S. Patel, S. Buta, M. Martin-Fernandez, , P. Soon-Shiong

This study evaluates a dual-antigen Ad5 vaccine delivered via subcutaneous and intranasal routes in mice, showing that combined prime-only delivery elicits strong humoral and T-cell responses against SARS-CoV-2.

bioRxiv · Mar 22, 2021Immunology

A recombinant ACE2 Triple Decoy that traps and neutralizes SARS-CoV-2 shows enhanced affinity for highly transmissible SARS-CoV-2 variants

S. Tanaka, G. Nelson, A. Olson, O. Buzko, W. Higashide, A. Shin, M. Gonzales, J. Taft, R. S. Patel, S. Buta, M. Martin-Fernandez, D. S. Bogunovic, P. R. Spilman, K. Niazi, S. Rabizadeh, P. Soon-Shiong

The paper develops an ACE2 Triple Decoy that maintains high affinity for SARS-CoV-2 variants and shows enhanced affinity for specific mutations.

bioRxiv · Mar 9, 2021Bioengineering

A Next Generation Bivalent Human Ad5 COVID-19 Vaccine Delivering Both Spike and Nucleocapsid Antigens Elicits Th1 Dominant CD4+, CD8+ T-cell and Neutralizing Antibody Responses

A. Rice, M. Verma, A. Shin, L. Zakin, P. Sieling, S. Tanaka, H. Adisetiyo, J. Taft, R. S. Patel, S. Buta, M. Martin-Fernandez, B. Morimoto, E. Gabitzsch, J. T. Safrit, J. Balint, , P. Soon-Shiong

This paper describes a bivalent hAd5 vaccine combining S-Fusion and N-ETSD antigens that elicits strong Th1-biased T-cell and neutralizing antibody responses in pre-clinical models.

bioRxiv · Jul 29, 2020 · PreprintImmunology

Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy

C. N. Gruber, M. Martin-Fernandez, F. Ailal, X. Qiu, J. Taft, J. Altman, J. Rosain, S. Buta, A. Bousfiha, J.-L. Casanova, J. Bustamante, D. Bogunovic

The paper identifies a homozygous STAT2 mutation causing type I interferonopathy by disrupting USP18 interaction and signal termination.

bioRxiv · Dec 12, 2019Immunology

Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Transcriptional and Biochemical Function

C. N. Gruber, J. Calis, S. Buta, G. Evrony, J. C. Martin, S. Uhl, R. Caron, L. Jarchin, D. Dunkin, R. Phelps, B. D. Webb, J. Saland, M. Merad, J. Orange, E. M. Mace, , D. Bogunovic

This study identifies a JAK1 mutation causing autoinflammation and shows its unique transcriptional and functional effects through single-cell analysis and clinical treatment.

bioRxiv · Oct 17, 2019Immunology